Some categories, like intimates, are already seeing shifts as shoppers buy clothes for new body sizes and routines, according ...
A popular class of drugs for treating diabetes and obesity may reduce addiction, including abuse of alcohol, tobacco, cannabis, opioids and cocaine, according to research published March 4 by ...
There's new evidence that GLP-1 drugs like Ozempic can reduce the risk of addiction. A study of more than 600,000 veterans followed for up to three years found that those who started taking a GLP-1 ...
Gina Roberts used to have this recurring nightmare: frantic and broke, she would search everywhere for a drink, but always the alcohol would remain out of reach. The dream would trigger such ...
The appetite-suppressing drugs decrease a person's intake of food and nutrients, which can impact bone health and lead to osteoporosis and gout Cara Lynn Shultz is a writer-reporter at PEOPLE. Her ...
The Food and Drug Administration (FDA) on Tuesday sent 30 telehealth companies warning letters about their “illegal” sales of compounded GLP-1s, building off increasing pressure to tamp down on the ...
The new pill form of popular GLP-1 drugs contains a compound that could cause troubling side effects. Historically, semaglutide, the active ingredient in Ozempic and Wegovy, has been administered via ...
North Carolina Poison Control is warning GLP-1 drug users to use caution when taking the medication. Poison control said last year it averaged one to two calls a day about GLP-1 drugs with 80 percent ...
Insurers said they had to withdraw coverage because the pricey medicines overwhelmed their budgets, forcing patients to either go off the drugs or pay for them out of pocket After years of struggling ...
Thirty warning letters were issued to telehealth companies for false and misleading claims about compounded GLP-1 receptor agonist products, the FDA announced on Tuesday. The letters primarily ...
The FDA has issued 30 warning letters to telehealth companies for making false or misleading claims about compounded GLP-1 products on their websites. The letters cite violations including claims ...